As of 3:59pm ET
| +0.10 / +0.25%|
The 2 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 49.50, with a high estimate of 55.00 and a low estimate of 44.00. The median estimate represents a +23.13% increase from the last price of 40.20.
The current consensus among 4 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.